Literature DB >> 9043475

Changing patterns and surgical results in adenocarcinoma of the oesophagus.

P Thomas1, C Doddoli, P Lienne, N Morati, X Thirion, L Garbe, R Giudicelli, P Fuentes.   

Abstract

BACKGROUND: Prognosis of oesophageal adenocarcinoma is notoriously dismal. To examine the changing patterns of and treatment strategies for this disease, the longitudinal experience of a single institution over 16 years is reported.
METHODS: The study comprised a retrospective review of 551 consecutive patients operated on for oesophageal cancer between 1979 and 1995, of whom 164 had adenocarcinoma. There were 13 women and 151 men whose mean age was 61 (range 17-82) years.
RESULTS: The prevalence of adenocarcinoma (P = 0.002), that of early tumours (P < or = 0.10), and the resectability rate (P < or = 0.05) increased throughout the period whereas operative mortality rate decreased (P < or = 0.10). Surgical approach changed without influence on long-term survival. Patients referred from endoscopic surveillance programmes for Barrett's oesophagus (n = 16) had an improved survival rate compared with that of non-surveyed patients (P < or = 0.01). Overall 5-year survival after oesophagectomy (17 per cent) improved for the period 1991-1995 when compared with 1979-1982 (P < or = 0.02). Univariate analysis identified tumour node metastasis (TNM) stage, number of diseased lymph nodes, invasion of the oesophageal stump and occurrence of a postoperative complication as significant prognostic variables (P < or = 0.05). Multivariate analysis demonstrated that T stage (P = 0.0002) was the main independent predictor.
CONCLUSIONS: Recent improvement of results reflects patient selection, increased prevalence of early tumours, and dramatic reduction of the risks from oesophagectomy. New therapeutic directions should be investigated for locally advanced tumours.

Entities:  

Mesh:

Year:  1997        PMID: 9043475

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

Review 1.  Should we continue oesophageal surgery in a district general hospital? A review of 200 consecutive cases.

Authors:  G H Dickson; R Waters; J Bull; V Kaul; J Sitzia
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

Review 2.  Surveillance in Barrett's oesophagus: a personal view.

Authors:  K K Basu; J S de Caestecker
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

3.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

Review 4.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Authors:  J Lagergren
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  Role of Rac1 in regulation of NOX5-S function in Barrett's esophageal adenocarcinoma cells.

Authors:  Jie Hong; Murray Resnick; Jose Behar; Jack Wands; Ronald A DeLellis; Weibiao Cao
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-27       Impact factor: 4.249

6.  Outcome of photodynamic therapy for early esophageal cancer.

Authors:  Young Koog Cheon; Wan Jung Kim; Joo Young Cho; Joon Seong Lee; Moon Sung Lee; Chan Sup Shim
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

Review 7.  Quality of complication reporting in the surgical literature.

Authors:  Robert C G Martin; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

8.  Rodent endosonography to monitor esophageal cancer.

Authors:  Navtej S Buttar; Maurits J Wiersema; Kenneth K Wang; Cathrine J DeMars; Ganapathy A Prasad; Lori S Lutzke
Journal:  Int J Gastrointest Cancer       Date:  2006

9.  Results of surgical therapy in patients with Barrett's adenocarcinoma.

Authors:  Luigi Bonavina; Albert Via; Raffaello Incarbone; Greta Saino; Alberto Peracchia
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

10.  A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection.

Authors:  Farhan Rashid; Naseem Waraich; Imran Bhatti; Shopan Saha; Raheela N Khan; Javed Ahmed; Paul C Leeder; Mike Larvin; Syed Y Iftikhar
Journal:  World J Surg Oncol       Date:  2010-01-06       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.